Ajax Therapeutics
Signal active
Organization
Contact Information
Overview
Ajax Therapeutics is an NYC-based biotechnology company applying computational chemistry and structure-based technologies to develop novel small molecules for hematologic malignancies
About
Industries
Biotechnology, Life Science, Medical
Founded
2019
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Ajax Therapeutics headquartered in United States, North America, operates in the Biotechnology, Life Science, Medical sector. The company focuses on Biotechnology and has secured $5.1B in funding across 36 round(s). With a team of 1-10 employees, Ajax Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Ajax Therapeutics, raised $8.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
0
Lead Investors
0
Total Funding Amount
$143.0M
Details
1
Ajax Therapeutics has raised a total of $143.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Late Stage Venture | 95.0M |
Investors
Ajax Therapeutics is funded by 24 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Vivo Capital | - | FUNDING ROUND - Vivo Capital | 95.0M |
| Scott Platshon | - | FUNDING ROUND - Scott Platshon | 95.0M |
| Ajax Therapeutics | - | FUNDING ROUND - Ajax Therapeutics | 95.0M |
| EcoR1 Capital | - | FUNDING ROUND - EcoR1 Capital | 95.0M |
Recent Activity
There is no recent news or activity for this profile.